Exosomes Derived From Umbilical Cord Mesenchymal Stem Cell therapy (Yihang (Suzhou) Biopharmaceutical)

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameExosomes Derived From Umbilical Cord Mesenchymal Stem Cell therapy (Yihang (Suzhou) Biopharmaceutical)
Drug Alias NameCB-Exo-A600
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYihang (Suzhou) Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYihang (Suzhou) Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A